Aegeline mitigates isoproterenol-induced myocardial infarction: insights from biochemical, histopathological, and in silico studies - Top-Institutions - MDSpire

Aegeline Reduces Myocardial Infarction Induced by Isoproterenol: Findings from Biochemical, Histopathological, and In Silico Analyses

  • By

  • Sami I. Alzarea

  • Muhammad Afzal

  • Misbahuddin Rafeeq

  • Alaa Hamed Habib

  • Tariq G. Alsahli

  • Omar Awad Alsaidan

  • Hassan H. Alhassan

  • Abdulaziz Ibrahim Alzarea

  • Aseel Awad Alsaidan

  • Nadeem Sayyed

  • Imran Kazmi

  • July 21, 2026

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Cardiology

  • #2

    Duke University School of Medicine
    Duke University School of Medicine

    Durham, North Carolina

    Key Differentiators

    • Cardiology

  • #3

    First Affiliated Hospital of Zhejiang University
    First Affiliated Hospital of Zhejiang University

    Hangzhou, Zhejiang

    Key Differentiators

    • Cardiology

Original Source(s)

Aegeline mitigates isoproterenol-induced myocardial infarction: insights from biochemical, histopathological, and in silico studies

  • by Sami I. Alzarea, Muhammad Afzal, Misbahuddin Rafeeq, Alaa Hamed Habib, Tariq G. Alsahli, Omar Awad Alsaidan, Hassan H. Alhassan, Abdulaziz Ibrahim Alzarea, Aseel Awad Alsaidan, Nadeem Sayyed, Imran Kazmi

  • July 21, 2026

Related Content

Efficacy and safety of different antithrombotic treatment regimens in patients undergoing transcatheter mitral valve repair and atrial fibrillation; A meta-analysis and systematic review

Exercise testing in athletes: an adjunct to diagnose arrhythmogenic cardiomyopathy?

Linear dose-response relationship between TyG-WC index and diastolic dysfunction: insights from restricted cubic spline and machine learning analysis